Subject: Smallcap Discoveries: Weekly Update July 13-17

Smallcap Discoveries:
Weekly Update - July 13-17
Smallcap Discoveries Select Portfolio

Immunoprecise Antibodies (IPA-TSX.V)
  • IPA announces discovery of additional, neutralizing antibodies, developed against SARS-CoV-2, discovered using Ligand Pharmaceuticals' genetically engineered OmniRat® strains producing human antibodies
  • The Company anticipates pre-clinical studies will begin summer 2020.
  • Press Release: https://tinyurl.com/y3s4dlxb
NameSilo Technologies (URl-CSE)
  • Recorded revenues of $7,568,804 in Q1 2020 - up 16.7%
  • Recorded adjusted EBITDA of $495,093 - up 104.1%
  • Recorded a net loss of $647,172.
  • $652,388 of net cash provided by operating activities in Q1 2020.
  • Press Release: https://tinyurl.com/y58wdm5r
Atlas Engineered Products (AEP-TSX.V)
  • Announced an acquisition of a truss manufacturer
  • Expanded geographical footprint into Lower Mainland region of BC
  • Purchase for $350,000, payable in cash, with 50% of the purchase price to be paid on closing and the remaining 50% payable in equal monthly installments over 3 years. 
  • Completion of the Asset Acquisition is expected to occur in the latter half of July 2020.
  • Press Release: https://tinyurl.com/y3efn22l
Lite Access Technologies (LTE-TSX.V)
RIWI Corp (RIW-CSE)
  • Insider Selling
  • 8,400 shares by BP Capital
Smallcap Discoveries Watchlist

AirIQ Inc (IQ-TSX.V)
  • Total revenue of $5,040,375 for the year ended March 31, 2020 increased by 37%
  • EBITDAS of $906,870 for the year ended March 31, 2020 increased by 88%
  • Net income of $713,499 for the year ended March 31, 2020 increased 209%
  • In October 2019 the Company increased its credit facility with Royal Bank of Canada to $750,000
  • Announced reinstatement of normal course issuer bid
  • Press Release: https://tinyurl.com/y5ve69a5
Innovotech (IOT-TSX.V)
  • Signed a 5-year Material Transfer and Collaboration Agreement with a global medical device company for its InnovoSIL(TM)-1 silver periodate (Ag5IO6) antimicrobial compound.
  • Innovotech will receive annual payments plus costs for new, divisional, and continuing patent applications related to the collaboration with our partner.
  • Press Release: https://tinyurl.com/y5sa7sx2

86 East 23rd Ave, v5v 1w9, Vancouver, Canada
You may unsubscribe or change your contact details at any time.